The 7MM soft tissue sarcoma (STS) market is estimated to reach USD 6,465.7 million by 2030 from USD 2,943.3 million in 2019 at a CAGR of 7.4%.

FILE - Jude Addo-Chidie, a Ph.D. student in agronomy at Purdue University, places a probe in soil as he takes samples from a corn field July 12 ... said Bill Anderson, CEO of Bayer, a multinational ...

The myasthenia gravis treatment market is anticipated to grow at a CAGR of 7.14% from US$1.973 billion in 2025 to US$2.785 ...

Industry Trends & Forecast Report 2027 Theglobal digital farming markethas reached USD 4,770.8 million in 2020. It is further projected to reach USD 10,702.3 million by 2027, at a CAGR of 12.7% during ...

Turbine’s virtual lab enables in silico experimentation using a vast library of cell models, patient-derived samples and virtual patients. By computationally predicting therapy effects, drug ...

Bayer is lobbying U.S. states to adjust their regulations in the battle to control costly litigation targeting its herbicide ...

Bayer Leverkusen CEO Fernando Carro has said ... but the fact is that we're a very professional club and we have to be prepared for anything," Carro told reporters on Monday.

FDA has granted full approval to Bayer’s larotrectinib (brand name Vitrakvi), a first-in-class tropomyosin receptor kinase (TRK) inhibitor, for treatment of solid tumors in both adult and pediatric ...

'WE ARE HAPPT WITH HIM' Leverkusen CEO Fernando Carro told the Blick newspaper that the club has no plans to sell Xhaka. Expressing his satisfaction with the experienced midfielder’s ...

Bayer Leverkusen's hopes of retaining their Bundesliga crown were dealt a huge blow following a 1-1 draw with St. Pauli on Sunday. (More Football News) Xabi Alonso's side are now eight points ...